Evidence map›Paper›PMID 42427493›Full record

ReviewAutophagy reports2026

Autophagy in the liver.

Elijah Burks, Jenna Copes, Kelly Nguyen, Albert Tawil-Brown, Shengmin Yan

Abstract readReview
In one paragraph

Review in Autophagy reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elijah BurksDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
Jenna CopesDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
Kelly NguyenDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
Albert Tawil-BrownDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
Shengmin YanDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, USA.ORCID https://orcid.org/0000-0003-4012-9557

Funding

Alcohol-associated cholestatic liver injury and mechanismsK01AA031305 · NIAAA · TULANE UNIVERSITY OF LOUISIANA · PI Shengmin Yan · 2023 to 2026
$563k
Plasma membrane rupture in alcohol-associated hepatitisR21AA031728 · NIAAA · TULANE UNIVERSITY OF LOUISIANA · PI Shengmin Yan · 2025 to 2026
$402k
NIAAA NIH HHS K01 AA031305NIAAA NIH HHS R21 AA031728
6 · The paper itself

Abstract

The liver plays a dynamic role in maintaining whole-body homeostasis through its control of nutrient metabolism, detoxification, and immune regulation. Autophagy, a conserved lysosomal degradation pathway, is central to these functions, enabling hepatocytes to adapt to fluctuations in nutrient availability, hormonal signals, and cellular stress. Hepatic autophagy is tightly regulated by nutrient and energy-sensing pathways, including AMPK, mTOR, the coordinated actions of insulin and glucagon, and transcriptional regulators TFEB, FOXO proteins, PPAR isoforms, FXR, and NRF2. Epigenomic mechanisms, chromatin remodeling complexes, and post-transcriptional regulators, such as microRNAs (miRNAs), RNA-binding proteins (RBPs), and liquid-liquid phase separation (LLPS), further refine autophagy gene expression and autophagosome formation. In physiological conditions, autophagy maintains hepatocyte integrity by supporting lipid, carbohydrate, and protein turnover and by clearing damaged or excess organelles through selective pathways such as mitophagy, lipophagy, pexophagy, ER-phagy, and xenophagy. Autophagy dysfunction contributes to the development of various liver diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-associated liver disease (ALD), cholestatic liver disease, liver fibrosis, and hepatocellular carcinoma (HCC). Understanding the diverse regulatory networks governing hepatic autophagy, along with the roles of autophagy in liver homeostasis, provides new opportunities for therapeutic intervention. This review summarizes existing findings on the role of autophagy in the liver, focusing on recent advances in the regulation of hepatic autophagy. It also highlights unresolved mechanisms and discusses how targeting autophagy may offer novel strategies for treating liver diseases.

Indexed as

Autophagyliver diseaseliver homeostasismacroautophagymetabolism

Identifiers

PMID42427493
PMCPMC13348988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.